Fig. 2From: Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective studyGraft-versus-host diseases after allo-HSCT. A Cumulative incidences of acute GvHD among different donor type cohorts. B Cumulative incidences of chronic GvHD in different donor type cohorts. C Cumulative incidences of acute GvHD between patients aged < 60y and ≥ 60y cohortsBack to article page